scholarly journals Surgical Stem Cell Therapy for Advanced Heart Failure Patients

2009 ◽  
Vol 5 (2) ◽  
pp. 13
Author(s):  
Brian A. Bruckner ◽  
Ali Ghodsizad ◽  
Matthias Loebe ◽  
Erik Beyer ◽  
Mahesh Ramchandani ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Advanced Heart Failure ◽  
Heart Failure Patients

Surgical Stem Cell Therapy For Advanced Heart Failure Patients

2009 ◽  
Vol 5 (2) ◽  
pp. 13-17
Author(s):  
Brian A. Bruckner ◽  
Ali Ghodsizad ◽  
Matthias Loebe ◽  
Erik Beyer ◽  
Mahesh Ramchandani ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Advanced Heart Failure ◽  
Heart Failure Patients

Circulatory support and stem cell therapy in the management of advanced heart failure: a concise review of available evidence

2019 ◽  
Vol 14 (6) ◽  
pp. 585-593
Author(s):  
Mohsin A Hussain ◽  
Martina Colicchia ◽  
Jessry Veerapen ◽  
Deshan Weeraman ◽  
Mihai-Nicolae Podaru ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Advanced Heart Failure ◽  
Circulatory Support ◽  
Concise Review

scholarly journals Stem cell therapy in patients with nonischemic heart failure

2021 ◽  
Vol 20 (Supplement_1) ◽  
Author(s):  
Z Tomsic ◽  
V Androcec
Keyword(s):  
Heart Failure ◽  
Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Treatment Options ◽  
Left Ventricular ◽  
Advanced Heart Failure ◽  
Left Ventricular Ejection ◽  
Ventricular Ejection Fraction

Abstract Funding Acknowledgements None Background Advanced chronic heart failure, characterized by a functional NYHA class III/IV, low LVEF, elevated B-type natriuretic peptides and other criteria’s is a big epidemiological problem, and its prevalence is increasing every year. There are many treatment options for patients with chronic and advanced heart failure. Treatment options include optimal medical therapy, treatment with cardiac resynchronization devices, left ventricular assist devices, heart transplantation and from 2006 treatment with CD 34 + stem cells. Method Patient inclusion criteria for stem cell therapy include dilated cardiomyopathy with no valve disease, hypertension or substance abuse, with optimal medical management for 6 months and a decreased left ventricular ejection fraction of <40%. Patients are treated with autologous pluripotent CD 34+ cells, which are mobilized in the blood stream with a bone marrow stimulant Filgrastim, administered subcutaneously for 5 days. The patients are educated by the nurses to do administer the injections at home, and have a contact number of our department in case of side effects. On the day of the procedure, stem cells are collected using the apheresis technique and then delivered transendocardialy in the catheterisation laboratory using the system for electromechanical mapping. If no complications develop, the patients can go home the next day. Results During follow-up visits patients treated with stem cells have an increased left ventricular ejection fraction, lower levels of NT-proBNP, increased distance of 6-minute walk test and increased survival compared with the control group. They also report better physical performance.  Conclusion  Stem cell therapy is thus a viable option and could become a mainstream therapy for the treatment of advanced heart failure in the future.

Stem Cell Therapy for Chronic and Advanced Heart Failure

2020 ◽  
Vol 17 (5) ◽  
pp. 261-270
Author(s):  
Gregor Poglajen ◽  
Sabina Frljak ◽  
Gregor Zemljič ◽  
Andraž Cerar ◽  
Renata Okrajšek ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Advanced Heart Failure

scholarly journals Combining Stem Cell Therapy for Advanced Heart Failure and Ventricular Assist Devices

ASAIO Journal ◽  
2018 ◽  
Vol 64 (5) ◽  
pp. e80-e87 ◽  
Author(s):  
Heidi J. Reich ◽  
Lawrence S. C. Czer ◽  
Danny Ramzy ◽  
Francisco Arabia ◽  
Jaime Moriguchi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Advanced Heart Failure ◽  
Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices

scholarly journals Stem Cell Therapy in Acute Coronary Syndrome

2006 ◽  
Vol 4 (1) ◽  
pp. 9-12
Author(s):  
Rajib Rajbhandari
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Acute Coronary Syndrome ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Cardiovascular Medicine ◽  
Coronary Syndrome

Acule coronary syndrome and congestive heart failure are still among challenging problems in the field of cardiovascular medicine despite many advances in the field. Stem cell therapy has come as a new hope and a promise for the hopeless.

Sign in / Sign up

Export Citation Format

Share Document